Systemic hemodynamics in young adults with the metabolic syndrome: The Cardiovascular Risk in Young Finns Study

Annals of Medicine

Volumn 42, Issue 8, 2010, Pages 612-621

  Koivistoinen, Teemu ^a   Aatola, Heikki ^a   Hutri Khnen, Nina ^a   Juonala, Markus ^b,c   Viikari, Jorma S A ^b   Laitinen, Tomi ^d   Taittonen, Leena ^e,f   Lehtimki, Terho ^a   Kbi, Tiit ^a   Raitakari, Olli T ^b,c   Khnen, Mika ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

^f VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Arterial stiffness; cardiovascular health; epidemiology; hemodynamics; metabolic syndrome; young adults

Indexed keywords

ADULT; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR RISK; FEMALE; FOLLOW UP; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HUMAN; IMPEDANCE CARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PULSE WAVE; STROKE; SYSTEMIC VASCULAR RESISTANCE;

ADULT; ARTERIES; BODY SURFACE AREA; CARDIAC OUTPUT; CARDIOGRAPHY, IMPEDANCE; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FINLAND; HEART RATE; HEMODYNAMICS; HUMANS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; STROKE VOLUME; VASCULAR RESISTANCE;

EID: 78249268796     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.515243     Document Type: Article

References (49)

1. Koskinen J, Kähönen M, Viikari JS, Taittonen L, Laitinen T, Rönnemaa T, et al. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study. Circulation. 2009;120:229-36.
2. Mattsson N, Rönnemaa T, Juonala M, Viikari JS, Jokinen E, Hutri-Kähönen N, et al. Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study. Eur Heart J. 2008;29: 784-91.
3. Ford ES. Risk for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769-78.
4. SipiläK, Koivistoinen T, Moilanen L, Nieminen T, Reunanen A, Jula A, et al. Metabolic syndrome and arterial stiffness: the Health 2000 Survey. Metabolism. 2007; 56. 320-6.
5. Li S, Chen W, Srinivasan SR, Berenson GS. Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: the Bogalusa Heart Study. Atherosclerosis. 2005;180:349-54.
6. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-41.
7. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10-15.
8. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002; 106: 2085-90.
9. Turhan H, Yasar AS, Yagmur J, Kurtoglu E, Yetkin E. The impact of metabolic syndrome on left ventricular function: evaluated by using the index of myocardial performance. Int J Cardiol. 2009;132:382-6
10. Gong HP, Tan HW, Fang NN, Song T, Li SH, Zhong M, et al. Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res Clin Pract. 2009;83: 300-7.
11. Chinali M, de Simone G, Roman MJ, Best LG, Lee ET, Russell M, et al. Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study. J Am Coll Cardiol. 2008;52:932-8.
12. Chemla D, Antony I, Lecarpentier Y, Nitenberg A. Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans. Am J Physiol Heart Circ Physiol. 2003;285:H614-20.
13. Abdelhammed AI, Smith RD, Levy P, Smits GJ, Ferrario CM. Noninvasive hemodynamic profi les in hypertensive subjects. Am J Hypertens. 2005;18:51S-9S.
14. Chirinos JA, Rietzschel ER, De Buyzere ML, De Bacquer D, Gillebert TC, Gupta AK, et al. Arterial load and ventricular-arterial coupling: physiologic relations with body size and effect of obesity. Hypertension. 2009;54:558-66.
15. Jern S, Bergbrant A, Björntorp P, Hansson L. Relation of central hemodynamics to obesity and body fat distribution. Hypertension. 1992;19:520-7.
16. Koskinen J, Magnussen CG, Taittonen L, Räsänen L, MikkiläV, Laitinen T, et al. Arterial structure and function after recovery from the metabolic syndrome. The Cardiovascular Risk in Young Finns Study. Circulation. 2010;121: 392-400.
17. Åkerblom HK, Viikari J, Uhari M, Räsänen L, Byckling T, Louhivuori K, et al. Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross-sectional study of 1980, and an account of the children's and families ' state of health. Acta Paediatr Scand Suppl. 1985;318: 49-63.
18. Raiko JR, Viikari JS, Ilmanen A, Hutri-Kähönen N, Taittonen L, Jokinen E, et al. Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: Levels and 6-year changes in risk factors. J Intern Med. 2010;267: 370-84.
19. Kööbi T, Kaukinen S, Turjanmaa V, Uusitalo AJ. Whole-body impedance cardiography in the measurement of cardiac output. Crit Care Med. 1997;25:779-85.
20. Kööbi T, Kaukinen S, Ahola T, Turjanmaa VM. Non-invasive measurement of cardiac output: whole-body impedance car-diography in simultaneous comparison with thermodilution and direct oxygen Fick methods. Intensive Care Med. 1997; 23:1132-7.
21. Kööbi T, Kaukinen S, Turjanmaa VM. Cardiac output can be reliably measured noninvasively after coronary artery bypass grafting operation. Crit Care Med. 1999;27:2206-11.
22. Kaukinen S, Kööbi T, Bi Y, Turjanmaa VM. Cardiac output measurement after coronary artery bypass grafting using bolus thermodilution, continuous thermodilution, and whole-body impedance cardiography. J Cardiothorac Vasc Anesth. 2003;17: 199-203.
23. Kööbi T, Kähönen M, Iivainen T, Turjanmaa V. Simultaneous non-invasive assessment of arterial stiffness and hemo-dynamics\a validation study. Clin Physiol Funct Imaging. 2003;23:31-6.
24. Aatola H, Hutri-Kähönen N, Juonala M, Viikari JS, Hulkkonen J, Laitinen T, et al. Lifetime risk factors and arterial pulse wave velocity in adulthood. The Cardiovascular Risk in Young Finns Study. Hypertension. 2010;55:806-11.
25. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientifi c statement. Circulation. 2005;112:e285-90.
26. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome\a new worldwide defi nition. Lancet. 2005;366:1059-62.
27. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. Diabet Med. 1999;16:442-43.
28. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-5.
29. Schillaci G, Pirro M, Vaudo G, Mannarino MR, Savarese G, Pucci G, et al. Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension. 2005;45:1078-82.
30. Assmann G, Schulte H, von Eckardstein A. Hypertriglyc-eridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol. 1996;77:1179-84.
31. Lind L, Hvarfner A, Pollare T, Lithell H, Ljunghall S. Fasting insulin, calcium metabolism and the electrocardiogram in hypertensive subjects. J Intern Med. 1992;232:335-9.
32. Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 1993;88:1431-6.
33. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001;103:102-7.
34. Dahan M, Siohan P, Viron B, Michel C, Paillole C, Gourgon R, et al. Relationship between left ventricular hypertrophy, myocardial contractility, and load conditions in hemodialysis patients: an echocardiographic study. Am J Kidney Dis. 1997;30:780-5.
35. Grossman E, Oren S, Messerli FH. Left ventricular mass and cardiac function in patients with essential hypertension. J Hum Hypertens. 1994;8:417-21.
36. Hara-Nakamura N, Kohara K, Sumimoto T, Lin M, Hiwada K. Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension. Am J Hypertens. 1994;7:1110-4.
37. Wang TD, Lee CM, Wu CC, Lee TM, Chen WJ, Chen MF, et al. The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris. Atherosclerosis. 1999;146:117-24.
38. Rogowski O, Steinvil A, Berliner S, Cohen M, Saar N, Kliuk Ben-Bassat O, et al. Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol. 2009;8:55.
39. Feldman RD, Bierbrier GS. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet. 1993;342:707-9.
40. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial dysfunction in metabolic syndrome: Prevalence, pathogenesis and management. Nutr Metab Cardiovasc Dis. 2010;20:140-6.
41. Koskinen T, Kähönen M, Jula A, Mattsson N, Laitinen T, Keltikangas-Järvinen L, et al. Metabolic syndrome and short-term heart rate variability in young adults. The Cardiovascular Risk in Young Finns study. Diabet Med. 2009;26: 354-61.
42. Miyaki A, Maeda S, Yoshizawa M, Misono M, Saito Y, Sasai H, et al. Effect of weight reduction with dietary intervention on arterial distensibility and endothelial function in obese men. Angiology. 2009;60:351-7.
43. Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC, et al. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension. 2007;49:1271-7.
44. Shinohara K, Shoji T, Kimoto E, Yokoyama H, Fujiwara S, Hatsuda S, et al. Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. J Atheroscler Thromb. 2005;12:205-10.
45. Shargorodsky M, Wainstein J, Gavish D, Leibovitz E, Matas Z, Zimlichman R. Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus. Am J Hypertens. 2003;16: 617-22.
46. Omvik P, Gerdts E, Myking OL, Lund-Johansen P. Long-term central hemodynamic effects at rest and during exercise of losa-rtan in essential hypertension. Am Heart J. 2000;140:624-30.
47. Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. The metabolic syndrome, car-diopulmonary fi tness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med. 2005;165:875-82.
48. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010;53:600-5.
49. Borch-Johnsen K, Wareham N. The rise and fall of the metabolic syndrome. Diabetologia. 2010;53:597-9.